Teva Pharmaceutical Q1 results in focus with eye on revenue numbers | Seeking Alpha
Teva Pharmaceutical Industries (NYSE:TEVA) shareholders are up 5.9% this past week, but still in the red over the last five years - Simply Wall St News
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times